Stockreport

Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available [Yahoo! Finance]

SIEMENS AG SPONS ADR  (SIEGY) 
NASDAQ:AMEX Investor Relations: siemens.com/investor
PDF Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use Brain Imag [Read more]